Clinical Trials

Fostamatinib – Warm Autoimmune Hemolytic Anemia

A Phase 3, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of fostamatinib in warm Autoimmune Hemolytic Anemia (wAIHA) subjects.

Phase 3 – wAIHA

 

Fostamatinib – COVID-19

A Phase 3, multi-center, randomized, double-blind, placebo-controlled, adaptive design study to evaluate the safety and efficacy of fostamatinib in COVID-19 subjects.

Phase 3 - COVID-19